Filing Details
- Accession Number:
- 0001415889-25-020782
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2025-07-31 18:51:09
- Reporting Period:
- 2025-07-29
- Filing Date:
- 2025-07-31
- Accepted Time:
- 2025-07-31 18:51:09
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1472012 | Immunome Inc. | IMNM | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1167496 | B Clay Siegall | C/O Immunome, Inc. 18702 N. Creek Parkway, Suite 100 Bothell WA 98011 | President And Ceo | No | No | No | No |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Employee Stock Option (right to buy) | Acquisiton | 2025-07-29 | 800,000 | $0.00 | 800,000 | $10.60 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 800,000 | 2035-07-28 | No | 4 | A | Direct |
Footnotes
- 25% of the shares subject to the options vest on July 29, 2026, and one-thirty-sixth (1/36th) of the remaining shares subject to the options shall vest every month thereafter.
Billionaire Hedge Funds
